CSS
GRTX

Cubist Systematic Strategies’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Cubist Systematic Strategies’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,056
Closed -$71.8K – 4489
2023
Q1 		$71.8K Buy
+28,056
New +$57.9K ﹤0.01% 3498

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Cubist Systematic Strategies's GRTX Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2023, closing a stake of 28,056 shares — an estimated $71.8K sold.

Cubist Systematic Strategies first reported a position in GRTX in Q1 2023 and held it in 1 quarter. The position peaked at $71.8K in Q1 2023. 55 funds tracked by Wall St. Rank hold GRTX as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 28,056 Galera Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $71.8K.
  • Cubist Systematic Strategies first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Cubist Systematic Strategies's Galera Therapeutics, Inc. Common Stock position peaked at $71.8K in Q1 2023.
  • 55 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.